Katherine D. Holland, MD, PhD

Co-Director, Child Neurophysiology Lab

Epilepsy Specialist, Division of Neurology

Academic Affiliations

Associate Professor, UC Department of Pediatrics

Mechanisms of epileptogenesis

MD: Washington University, St. Louis, MO, 1991.

PhD (pharmacology): Washington University, St. Louis, MO, 1991.

Internship: Children's Hospital, Boston, MA.

Residency: St Louis Children's Hospital, St. Louis, MO.

Certification: Neurology with added qualification in pediatric neurology, 2000.

View PubMed Publications

Standridge SM, Holland KD, Horn PS. Cardiac arrhythmias and ictal events within an epilepsy monitoring unit.  Pediatr Neurol. 2010 Mar;42(3):201-5.

Holland KD, Monahan S, Morita D, Vartzelis G, Glauser TA. Valproate in children with newly diagnosed idiopathic generalized epilepsy. Acta Neurol Scand. 2010 Mar;121(3):149-53.

Holland KD, Kearney JA, Glauser TA, Buck G, Keddache M, Blankston JR, Glaaser IW, Kass RS, Meisler MH. Mutation of sodium channel SCN3A in a patient with cryptogenic pediatric partial epilepsy.  Neurosci Lett. 2008 Mar 5;433(1):65-70.

Holland KD, Glauser TA. Response to carbamazepine in children with newly diagnosed partial onset epilepsy. Neurology. 2007 Aug 7;69(6):596-9.

Holland KD, Fleming MT, Cheek S, Moran JL, Beier DR, Meisler MH. De novo exon duplication in a new allele of mouse Glra1 (spasmodic). Genetics. 2006 Dec;174(4):2245-7.